Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Value in Oncology
Value Frameworks in Oncology: Economic Analyses of 4 Clinical Interventions
By
Chase Doyle
Value in Oncology
September 2016, Vol 7, No 8
In the past year, the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO), and the Institute for Clinical and Economic Review (ICER) have introduced frameworks that seek to determine clinical value in relation to cost for a variety of cancer treatments.
Read Article
How to Reduce Financial Toxicity in Patients with Cancer
By
Chase Doyle
Financial Toxicity
,
Value in Oncology
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
In addition to affecting patient well-being and quality of life, financial toxicity has been shown to worsen survival outcomes because of nonadherence to drug therapy. Although policy interventions, improvements in benefit designs, and adjustments to reimbursement may help reduce costs for patients in the long-term, immediate changes are needed to alleviate financial burden, said Yousuf Zafar, MD, MHS, of the Duke Cancer Institute, Durham, NC, at ASCO 2016.
Read Article
Transition from Branded to Generic Cancer Drugs Significantly Increases Treatment Cost-Effectiveness
By
Chase Doyle
Value in Oncology
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
An economic analysis of oncology regimens that were previously evaluated in trials conducted by the Canadian Cancer Society Research Institute has shown that the transition from branded to generic drug costs has a considerable impact on the cost-effectiveness and cost-utility of treatment.
Read Article
Aggressive End-of-Life Care Continues to Be Offered to Younger Patients with Cancer
By
Phoebe Starr
End-of-Life Care
,
Value in Oncology
,
Policies & Guidelines
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
Aggressive end-of-life care for patients with terminal cancer and other illnesses is costly and not recommended. ASCO recommends that patients with terminal cancer should receive palliative care rather than interventions that do not prolong life but do add to suffering.
Read Article
Out-of-Pocket Costs Linked to Reduced Adherence to Oral Oncolytics
By
Chase Doyle
Value in Oncology
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
Access and adherence to long-term cancer therapies are emerging as major public health issues around the world, as high out-of-pocket costs for oral oncolytics are linked to nonadherence that can directly affect patient outcomes, said Dawn L. Hershman, MD, MS, Professor of Medicine and Epidemiology, Columbia University Medical Center, New York, NY, at ASCO 2016.
Read Article
ASCO President Addresses Quality Care Through Collective Wisdom
By
Wayne Kuznar
Quality Care
,
Value in Oncology
,
Policies & Guidelines
August 2016, Vol 7, No 7, Special Issue: Payers’ Perspectives in Oncology
In her presidential address, Julie M. Vose, MD, MBA, Chief of the Oncology/Hematology Division, University of Nebraska Medical Center, Omaha, highlighted the importance of multimodal care and its effect on the quality of care and enhancement of clinical trial participation among patients with cancer.
Read Article
Opportunities for Shared Decision-Making in Clinical Practice
By
Chase Doyle
Value in Oncology
July 2016, Vol 7, No 6
The National Academy of Medicine recommends a shared decision-making approach when discussing medical treatments; however, an overview of evidence presented by Terrance Lynn Albrecht, PhD, Associate Center Director, Population Sciences, Karmanos Cancer Institute, and Chief of Oncology, Wayne State University School of Medicine, Detroit, at the 2016 American Society of Clinical Oncology annual meeting suggests that clinicians are not very effective in following this recommendation.
Read Article
Cost of Drugs and Affordability Don’t Always Jibe
By
Phoebe Starr
Value in Oncology
July 2016, Vol 7, No 6
An international collaborative pilot study found large differences by country in retail prices for 23 cancer drugs, with the highest retail prices in the United States and the lowest in India and South Africa. Higher prices, however, did not mean that the drugs were less affordable, according to lead investigator Daniel Goldstein, MD, Rabin Medical Center, Petach Tikvah, Israel, who presented the results at the 2016 ASCO annual meeting.
Read Article
Chemotherapy Use in Breast Cancer Declines with Gene-Based Assay
By
Charles Bankhead
Chemotherapy
,
Value in Oncology
,
Personalized Medicine
June 2016, Vol 7, No 5
Women with clinicopathologic high-risk breast cancer had nearly a 50% reduction in prescription chemotherapy, with no increased risk for metastatic recurrence when a cancer gene-based assay was used to guide treatment decision-making, according to new data presented at the 2016 American Association for Cancer Research meeting.
Read Article
The New World of Biosimilars
By
Meg Barbor, MPH
Value in Oncology
,
Biosimilars
June 2016, Vol 7, No 5
Read Article
Page 4 of 7
1
2
3
4
5
6
7
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma